BAIBYS™ Unveils Advanced IVF System to Revolutionize Fertility Treatment Across Europe

BAIBYS™ Unveils a Revolutionary IVF System

BAIBYS™, an Israeli startup recognized for its advancements in AI-powered microrobotics, has announced the official CE marking of its groundbreaking In Vitro Fertilization (IVF) system designed to transform male fertility treatments. This new technology embodies a significant step forward in addressing infertility, which affects many couples worldwide.

With male infertility being responsible for around 50% of global cases, the need for innovative solutions has never been clearer. BAIBYS™ has developed a sophisticated, autonomous sperm selection system that leverages advanced AI algorithms and machine vision technology to select optimal sperm cells based on precise criteria. This revolutionary process not only enhances standardization in sperm selection but also drastically reduces the operation time, efficiently isolating ideal sperm cells within minutes.

Founded in 2020 by Dr. Nino Guy Cassuto, a male fertility specialist, and Gal Golov, an electro-optics expert, BAIBYS™ has positioned itself at the forefront of fertility technology. The system’s AI analyzes living sperm cells at high magnification, utilizing peer-reviewed morphological and motility parameters for its selection process. By automating these complex tasks, BAIBYS™ addresses key challenges faced by clinicians in conventional sperm selection, paving the way for improved IVF outcomes and higher success rates.

The CE marking is a critical milestone, allowing BAIBYS™ to market its system across Europe, starting a new chapter for fertility clinics across the continent. As the company gears up for commercial deployment, they are also planning a series of clinical trials throughout 2025 to validate and further refine their technology.

The implications of BAIBYS™’ work extend far beyond the reach of individual treatment. With global sperm counts reportedly declining by approximately 50% over the last fifty years, their technology offers a timely response to a growing public health challenge. As the company prepares to tap into the rising demand for IVF services in Europe, plans for expansion into the USA and Asia are also underway, highlighting the urgent need and potential impact of their innovation.

In summary, BAIBYS™ stands out as a leader in AI-driven fertility solutions with a commitment to improving IVF success rates while reducing risks associated with traditional procedures. Their cutting-edge technology is set to reshape the landscape of fertility treatment, striving to alleviate the emotional and physical burdens faced by couples dealing with infertility.

For more information, please contact:
Yaron Silberman, PhD, MBA, CEO
Media Relations
[email protected]
+972 77 332-0302